English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  53022441    線上人數 :  968
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

跳至:
或輸入年份:
從最近的開始 由舊到新排序

顯示項目 2261121-2261145 / 2349066 (共93963頁)
<< < 90440 90441 90442 90443 90444 90445 90446 90447 90448 90449 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-02-21T03:52:34Z Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non�VSmall-cell Lung Cancer Patients Wu T.-H.; Hsiue E.H.-C.; JIH-HSIANG LEE; Lin C.-C.; Liao W.-Y.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H.
臺大學術典藏 2022-02-21T03:52:34Z Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors Liao B.-C.; Bai Y.-Y.; JIH-HSIANG LEE; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C.
臺大學術典藏 2022-02-21T03:52:35Z Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; JIH-HSIANG LEE; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H.
臺大學術典藏 2022-02-21T03:52:35Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏 2022-02-21T03:52:36Z Optimal management of EGFR-mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapy Liao B.-C.; Lin C.-C.; JIH-HSIANG LEE; Yang J.C.-H.
臺大學術典藏 2022-02-21T03:52:36Z Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line tyrosine kinase inhibitors Chang I.-S.; Jiang S.S.; Yang J.C.-H.; Su W.-C.; Chien L.-H.; Hsiao C.-F.; JIH-HSIANG LEE; Chen C.-Y.; Chen C.-H.; Chang G.-C.; Wang Z.; Lo F.-Y.; Chen K.-Y.; Wang W.-C.; Chen Y.-M.; Huang M.-S.; Tsai Y.-H.; Su Y.-C.; Hsieh W.-S.; Shih W.-C.; Shieh S.-H.; Yang T.-Y.; Lan Q.; Rothman N.; Chen C.-J.; Chanock S.J.; Yang P.-C.; Hsiung C.A.
臺大學術典藏 2022-02-21T03:52:36Z New data on clinical decisions in NSCLC patients with uncommon EGFR mutations Wu T.; Hsiue E.H.; JIH-HSIANG LEE; Lin C.; Yang J.C.
臺大學術典藏 2022-02-21T03:52:37Z A systematic review and meta-analysis of individual patient data on the impact of the BIM deletion polymorphism on treatment outcomes in epidermal growth factor receptor mutant lung cancer Soh S.X.; Siddiqui F.J.; Allen J.C.; Kim G.W.; Lee J.C.; Yatabe Y.; Soda M.; Mano H.; Soo R.A.; Chin T.-M.; Ebi H.; Yano S.; Matsuo K.; Niu X.; Lu S.; Isobe K.; JIH-HSIANG LEE; Yang J.C.; Zhao M.; Zhou C.; Lee J.-K.; Lee S.-H.; Lee J.Y.; Ahn M.-J.; Tan T.J.; Tan D.S.; Tan E.-H.; Ong S.T.; Lim W.-T.
臺大學術典藏 2022-02-21T03:52:37Z Update on recent preclinical and clinical studies of T790M mutant-specific irreversible epidermal growth factor receptor tyrosine kinase inhibitors Liao B.-C.; Lin C.-C.; JIH-HSIANG LEE; Yang J.C.-H.
臺大學術典藏 2022-02-21T03:52:37Z Profile of the therascreen? EGFR RGQ PCR kit as a companion diagnostic for gefitinib in non-small cell lung cancer Hsiue E.H.-C.; JIH-HSIANG LEE; Lin C.-C.; Yang J.C.-H.
臺大學術典藏 2022-02-21T03:52:38Z Safety of gefitinib in non-small cell lung cancer treatment Hsiue E.H.-C.; JIH-HSIANG LEE; Lin C.-C.; Yang J.C.-H.
臺大學術典藏 2022-02-21T03:52:38Z Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis Liao B.-C.; JIH-HSIANG LEE; Lin C.-C.; Chen Y.-F.; Chang C.-H.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H.
臺大學術典藏 2022-02-21T03:52:38Z High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country Lin C.-H.; Shen C.-Y.; JIH-HSIANG LEE; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; Chen W.-W.; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏 2022-02-21T03:52:39Z Enhancer of rudimentary homolog regulates DNA damage response in hepatocellular carcinoma Weng M.-T.; Tung T.-H.; JIH-HSIANG LEE; Wei S.-C.; Lin H.-L.; Huang Y.-J.; Wong J.-M.; Luo J.; Sheu J.-C.
臺大學術典藏 2022-02-21T03:52:39Z Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer JIH-HSIANG LEE; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H.
臺大學術典藏 2022-02-21T03:52:39Z Characterization of fibroblast growth factor receptor 1 in small-cell lung cancer Thomas A.; JIH-HSIANG LEE; Abdullaev Z.; Park K.-S.; Pineda M.; Saidkhodjaeva L.; Miettinen M.; Wang Y.; Pack S.D.; Giaccone G.
臺大學術典藏 2022-02-21T03:52:40Z The janus kinases inhibitor AZD1480 attenuates growth of small cell lung cancers in vitro and in vivo JIH-HSIANG LEE; Park K.-S.; Alberobello A.T.; Kallakury B.; Weng M.-T.; Wang Y.; Giaccone G.
臺大學術典藏 2022-02-21T03:52:40Z Role of CYB5A in pancreatic cancer prognosis and autophagy modulation Giovannetti E.; Wang Q.; Avan A.; Funel N.; Lagerweij T.; JIH-HSIANG LEE; Caretti V.; Van Der Velde A.; Boggi U.; Wang Y.; Vasile E.; Peters G.J.; Wurdinger T.; Giaccone G.
臺大學術典藏 2022-02-21T03:52:40Z Capillary isoelectric-focusing immunoassays to study dynamic oncoprotein phosphorylation and drug response to targeted therapies in non-small cell lung cancer Chen J.-Q.; JIH-HSIANG LEE; Herrmann M.A.; Park K.-S.; Heldman M.R.; Goldsmith P.K.; Wang Y.; Giaccone G.
臺大學術典藏 2022-02-21T03:52:41Z MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinib Huang M.-H.; JIH-HSIANG LEE; Chang Y.-J.; Tsai H.-H.; Lin Y.-L.; Lin A.M.Y.; Yang J.C.H.
臺大學術典藏 2022-02-21T03:52:41Z Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells Weng M.-T.; JIH-HSIANG LEE; Wei S.-C.; Li Q.; Shahamatdar S.; Hsu D.; Schetter A.J.; Swatkoski S.; Mannan P.; Garfield S.; Gucek M.; Kim M.K.H.; Annunziata C.M.; Creighton C.J.; Emanuele M.J.; Harris C.C.; Sheu J.-C.; Giaccone G.; Luo J.
臺大學術典藏 2022-02-21T03:52:41Z Loss of 18q22.3 involving the carboxypeptidase of glutamate-like gene is associated with poor prognosis in resected pancreatic cancer JIH-HSIANG LEE; Giovannetti E.; Hwang J.-H.; Petrini I.; Wang Q.; Voortman J.; Wang Y.; Steinberg S.M.; Funel N.; Meltzer P.S.; Wang Y.; Giaccone G.
臺大學術典藏 2022-02-21T03:52:42Z Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors Voortman J.; JIH-HSIANG LEE; Killian J.K.; Suuriniemi M.; Wang Y.; Lucchi M.; Smith Jr. W.I.; Meltzer P.; Wang Y.; Giaccone G.
臺大學術典藏 2022-02-21T03:52:42Z MicroRNA expression and clinical outcome of small cell lung cancer JIH-HSIANG LEE; Voortman J.; Dingemans A.-M.C.; Voeller D.M.; Pham T.; Wang Y.; Giaccone G.
臺大學術典藏 2022-02-21T03:52:42Z Good response to pemetrexed in patients of lung adenocarcinoma with epidermal growth factor receptor (EGFR) mutations Wu S.-G.; Yang C.-H.; Yu C.-J.; JIH-HSIANG LEE; Hsu Y.-C.; Chang Y.-L.; Shih J.-Y.; Yang P.-C.

顯示項目 2261121-2261145 / 2349066 (共93963頁)
<< < 90440 90441 90442 90443 90444 90445 90446 90447 90448 90449 > >>
每頁顯示[10|25|50]項目